<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Initial therapy for &lt;em&gt;Helicobacter pylori&lt;/em&gt; eradication in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Initial therapy for <em>Helicobacter pylori</em> eradication in children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Initial therapy for <em>Helicobacter pylori</em> eradication in children</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm outlines selection of initial therapy for <em>H. pylori</em> eradication in children based on antibiotic susceptibility of the child's <em>H. pylori</em> isolate. Other strategies are required for children with persistent <em>H. pylori</em> infection after completing initial therapy. For details, dosing, and strategies for patients with penicillin allergy, refer to UpToDate topic on <em>H. pylori</em> infection in children and related tables.</div><div class="graphic_footnotes"><p><em>H. pylori</em>: <em>Helicobacter pylori</em>; CLA: clarithromycin; PPI: proton pump inhibitor; AMO: amoxicillin; MET: metronidazole.</p>
<p>* Because antibiotic resistance is common, selection of an appropriate regimen should be made based on antibiotic susceptibility testing for the individual patient, if at all possible. Susceptibility testing is particularly important for children with persistent <em>H. pylori</em> infection after an initial attempt at eradication. If susceptibility testing is not available ("unknown" pathways above), use the same regimen as for CLA and MET resistance.</p>
<p>¶ Bismuth-based quadruple therapy consists of bismuth-PPI-AMO-MET (for age &lt;8 years) or bismuth-PPI-MET-TET (for age ≥8 years). We use bismuth-based regimens when indicated. In the United States, bismuth is available only as bismuth subsalicylate, so we avoid it if the child has any flu-like illness because of theoretical concerns about Reye syndrome due to the subsalicylate component.</p>
Δ Where bismuth is available, bismuth-based quadruple therapy is preferred due to better eradication compared with triple therapy (PPI-AMO-MET with high-dose AMO).</div><div class="graphic_reference">Adapted with permission from Wolters Kluwer Health, Inc.: Jones NL, Koletzko S, Goodman K, et al. Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (Update 2016). J Pediatr Gastroenterol Nutr 2017; 64(6):991-1003. Copyright © 2017 European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. <a href="https://journals.lww.com/jpgn/pages/default.aspx" target="_blank">https://journals.lww.com/jpgn/pages/default.aspx</a>.</div><div id="graphicVersion">Graphic 141530 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
